Back to Market返回行情

PDEX Pro-Dex, Inc.

USHealthcare
$62.89+1.37%ClosedMarket Cap: $200.8M

As of 2026-07-10 16:00

Why PDEX matters now

Pro-Dex, Inc. (PDEX) is a US stock in Healthcare. The latest InvestLog snapshot shows $62.89 with +1.37% on the session and $200.8M in market capitalization; recent performance reads 1-month +5.91% and YTD +67.28%.

The latest financial table shown here is Q3 2026, with revenue of $19.9M, net income of $3.9M, and EPS of $1.20. Investors can compare that operating picture with valuation signals such as P/E 14.32 and FCF yield 3.4%.

The latest indexable market news headline is "Pro-Dex: Still A Buy, But Don't Chase" from Seeking Alpha.

Additional event context on this page matters because analyst consensus is Buy with a median target of $—; recent insider activity includes Van Kirk Richard Lee Jr filing S-Sale. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

14.32

PEG

0.21

P/B

4.56

P/S

2.75

EV/EBITDA

10.99

DCF Value

$137.96

FCF Yield

3.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

27.8%

Operating Margin

14.5%

Net Margin

16.1%

ROE

29.1%

ROA

16.0%

ROIC

12.3%

Financials

PeriodRevenueNet IncomeEPS
Q3 2026$19.9M$3.9M$1.20
Q2 2026$18.7M$2.2M$0.66
Q1 2026$18.5M$4.7M$1.40
Q4 2025$17.5M$1.2M$0.36

Analyst Ratings

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

Strong Buy: 0Buy: 1Hold: 0Sell: 0Strong Sell: 0
Ascendiant CapitalBuy
2026-05-12

Trading Activity

Insider Trades

Van Kirk Richard Lee Jrdirector, officer: Chief Executive Officer
Sell2026-05-26
Van Kirk Richard Lee Jrdirector, officer: Chief Executive Officer
Sell2026-05-26
Van Kirk Richard Lee Jrdirector, officer: Chief Executive Officer
Sell2026-05-26
Van Kirk Richard Lee Jrdirector, officer: Chief Executive Officer
Sell2026-05-26
Van Kirk Richard Lee Jrdirector, officer: Chief Executive Officer
Sell2026-05-26

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

US

Exchange

Beta

-0.00

Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical drivers and shavers, available in both battery-powered and electric models, often equipped with multi-functional capabilities. These instruments are primarily employed in orthopedic, thoracic, and craniomaxillofacial surgical procedures. Beyond its core manufacturing, Pro-Dex also offers expert consulting services, covering engineering, quality assurance, and regulatory compliance. Furthermore, the company manufactures and distributes rotary air motors to various industrial clients. Founded in 1978, Pro-Dex, Inc. maintains its corporate headquarters in Irvine, California.